+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Automated Compounding Devices Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924780
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Automated Compounding Devices Market grew from USD 2.56 billion in 2024 to USD 2.84 billion in 2025. It is expected to continue growing at a CAGR of 10.59%, reaching USD 4.69 billion by 2030.

Automated compounding devices have emerged as a pivotal innovation in pharmaceutical preparation, combining precision engineering with advanced software to ensure consistent, error-free medication dispensing. Manual compounding processes, historically vulnerable to human error and variability, are now being replaced by integrated systems that deliver standardized output, reduce waste, and improve patient safety. This executive summary provides a concise yet comprehensive overview of the market’s current dynamics, spotlighting transformative shifts, tariff impacts, segmentation, regional developments, and competitive landscapes. It underscores the technologies and strategies driving adoption among hospitals, pharmacies, ambulatory surgical centers, and homecare settings. By transitioning from manual protocols to automated platforms, healthcare providers are achieving greater operational efficiency and supporting personalized therapy regimens. Stakeholders will gain insights into regulatory drivers, supply chain considerations, and technology advancements shaping the trajectory of automated compounding. This foundational introduction sets the stage for a detailed analysis that will guide strategic decision-making, enable resource optimization, and unlock new avenues for sustainable growth in a rapidly evolving healthcare environment.

Transformative Shifts Redefining the Compounding Landscape

The landscape of compounding automation is undergoing rapid transformation, driven by four primary forces. First, heightened regulatory scrutiny is compelling providers to adopt systems that ensure traceability, compliance, and real-time quality control. Second, the integration of robotics, artificial intelligence, and machine learning is enabling adaptive dosing algorithms and predictive maintenance, reducing downtime and extending device lifespans. Third, the shift toward value-based healthcare is incentivizing cost-efficiency and outcome transparency, prompting budget holders to invest in platforms that minimize waste and error. Finally, the growing demand for personalized medicine-especially in oncology and chronic disease management-has elevated the importance of on-demand and scheduled automation capable of producing patient-specific doses at scale.

These shifts are interdependent. Regulatory requirements accelerate technological innovation, while AI-driven analytics optimize compliance workflows. Value-based models reinforce the business case for upfront capital investment. Meanwhile, personalized therapy paradigms drive demand for modular, flexible systems. Together, these forces are redefining how healthcare organizations approach medication preparation, creating an ecosystem where data integration, process standardization, and patient safety converge.

Assessing the Cumulative Impact of U.S. Tariffs in 2025

In 2025, new U.S. tariffs on imported materials and devices will exert significant pressure on cost structures across the automated compounding ecosystem. Composite materials, metals, and plastics-core components of device housings and dispensing modules-will incur higher import duties, raising production costs for global and domestic manufacturers alike. Pharmaceutical providers may confront increased capital expenditure for device acquisition and elevated service fees for maintenance contracts.

These tariffs are accelerating several strategic responses. Tier-one suppliers are exploring nearshoring options to localize manufacturing and mitigate duty burdens. Procurement teams are renegotiating master service agreements to lock in favorable pricing before tariff escalations take effect. Some device OEMs are redesigning components to substitute higher-tariff materials with locally sourced alternatives. In parallel, technology providers are bundling compounding software and inventory management modules to deliver greater value and offset incremental hardware expenses.

While short-term margin compression is likely, these dynamics are driving long-term resilience. By fostering supply chain diversification, encouraging material innovation, and strengthening domestic manufacturing capabilities, the industry is poised to emerge more agile and cost-effective in a post-tariff environment.

Deep-Dive into Market Segmentation Insights

A nuanced understanding of market segmentation reveals the multifaceted nature of demand and adoption patterns. Based on product type, demand spans integrated devices that combine compounding automation with built-in verification, semi-automated devices requiring human oversight for certain steps, and stand-alone units designed for specific formulations. Examining mode of automation highlights the contrasting requirements for on-demand automation-ideal for emergency or as-needed doses-and scheduled automation suited for high-volume batch preparation.

End-user segmentation underscores diverse use cases: ambulatory surgical centers prioritize compact, rapid-deployment systems; homecare settings emphasize ease of use and remote monitoring capabilities; hospitals range from general facilities requiring broad application support to specialty hospitals focusing on niche therapies; and pharmacies are subdivided into hospital pharmacies integrating with electronic health records, online pharmacies scaling for distance dispensing, and retail pharmacies catering to community-based compounding services.

Application-driven demand is centered on chemotherapy compounding, diabetes management involving insulin and adjunct therapies, nutrition therapy with enteral and parenteral modalities, and pain management preparations. Technology segmentation differentiates between automated compounders designed for mechanical precision, robotic technology offering high throughput and sterility assurance, and software solutions encompassing compounding software and inventory management software for end-to-end workflow control.

User interface preferences range from basic button-operated panels to mobile interface integration enabling remote supervision, and touch-screen interfaces that support intuitive operation and training. Dosage forms cover inhalable solutions for respiratory therapies, injectables for parenteral applications, orals for capsule and liquid formulations, and topical solutions. Lastly, material type differentiation among composite materials, metal, and plastic influences device durability, sterilization protocols, and lifecycle costs. This comprehensive segmentation framework allows stakeholders to tailor product development, marketing strategies, and service offerings to precise market niches.

Regional Dynamics Shaping Growth Trajectories

Regional dynamics continue to shape competitive advantages and investment priorities. In the Americas, robust healthcare infrastructure and expansive distribution networks support rapid adoption of advanced compounding platforms; reimbursement policies in the United States incentivize error-reduction technologies, while Latin American markets display growing interest in modular and scaled solutions.

Within Europe, Middle East & Africa, stringent European Medicines Agency guidelines are driving adoption of closed-system compounding devices to mitigate contamination risks. In the Middle East, government-funded healthcare modernization programs are fueling capital investments, while African markets seek cost-effective semi-automated solutions to address workforce constraints.

Asia-Pacific markets exhibit heterogeneous growth trajectories: established economies in Japan and South Korea prioritize next-generation robotics and AI-enabled monitoring, whereas China and India are emerging as manufacturing hubs for both components and complete systems, balancing cost leadership with accelerating quality standards. Southeast Asian nations are piloting portable and homecare-oriented compounding platforms to meet rising chronic disease burdens and expand remote care capabilities.

Competitive Landscape and Leading Players

The competitive landscape is anchored by a mix of global healthcare conglomerates, specialized automation vendors, and innovative robotics startups. Major players such as Amerisource Bergen Corporation and McKesson Corporation leverage vast distribution channels to bundle compounding hardware with pharmaceutical logistics services. Medical device leaders including B. Braun SE, Baxter Healthcare Corporation, and Becton, Dickinson and Company focus on integrating advanced safety features and closed-system designs to comply with evolving regulations.

Technology innovators like ARxIUM Inc., Codonics Inc., and Omnicell, Inc. are advancing software-driven platforms that unify compounding, verification, and inventory management into cohesive workflows. Robotics specialists including Health Robotics SRL and Tecan Group Ltd. are applying collaborative robotics and high-throughput automation to meet hospital and retail pharmacy needs. Regional champions such as Yuyama Co., Ltd. bring deep market expertise in Asia, while Loccioni Group and Meditecno S.r.l. drive bespoke solutions across Europe.

Emerging players such as ForHealth Technologies and Quirem Medical B.V. are developing niche offerings for oncology and specialized therapies. Simultaneously, conglomerates like Fresenius Kabi AG, Grifols International S.A., and Terumo Corporation pursue strategic partnerships and acquisitions to expand their digital and robotics portfolios. This dynamic ecosystem requires continuous innovation, strategic alliances, and robust service models to maintain competitive differentiation.

Actionable Recommendations for Industry Leaders

To capitalize on growth opportunities and mitigate emerging risks, industry leaders should consider the following strategic imperatives:
  1. Invest in modular, open-architecture platforms that support rapid configuration for diverse applications and dosage forms, ensuring flexibility in response to evolving therapy demands.
  2. Accelerate the integration of AI-powered analytics and IoT-enabled sensors to deliver predictive maintenance, real-time quality assurance, and data-driven workflow optimization.
  3. Strengthen regional supply chains through strategic nearshoring partnerships and localized manufacturing to reduce tariff exposure and improve lead-time reliability.
  4. Expand value-added service offerings-including training, validation support, and remote monitoring-to enhance customer retention and create recurring revenue streams.
  5. Pursue targeted collaborations with software providers to develop unified compounding and inventory management solutions, addressing regulatory compliance and operational transparency.

Conclusion: Charting the Future of Automated Compounding

Automated compounding devices are at the nexus of patient safety, operational efficiency, and personalized therapy delivery. Over the next decade, success will be determined by an organization’s ability to navigate regulatory complexities, harness advanced technologies, and anticipate shifting market demands. Stakeholders must adopt a holistic strategy that aligns product innovation with service excellence, underpinned by data integration and supply chain resilience.

By leveraging the detailed segmentation, regional insights, and competitive analysis presented in this summary, decision-makers can prioritize investments, optimize product portfolios, and cultivate strategic partnerships. Embracing a proactive approach to tariff mitigation, digital transformation, and flexible automation will position companies to capture new market segments and drive sustainable growth. Ultimately, the convergence of robotics, software, and regulatory compliance will define the next frontier in compounding automation, catalyzing safer, more efficient medication delivery worldwide.

Market Segmentation & Coverage

This research report categorizes the Automated Compounding Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Integrated Devices
  • Semi-Automated Devices
  • Stand-Alone Devices
  • On-Demand Automation
  • Scheduled Automation
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Hospitals
    • General Hospitals
    • Specialty Hospitals
  • Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Chemotherapy
  • Diabetes Management
  • Nutrition Therapy
    • Enteral Nutrition
    • Parenteral Nutrition
  • Pain Management
  • Automated Compounders
  • Robotic Technology
  • Software Solutions
    • Compounding Software
    • Inventory Management Software
  • Button Operated
  • Mobile Interface
  • Touch-Screen Interface
  • Inhalable Solutions
  • Injectables
  • Orals
  • Topical Solutions
  • Composite Materials
  • Metal
  • Plastic

This research report categorizes the Automated Compounding Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Automated Compounding Devices Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Amerisource Bergen Corporation
  • ARxIUM Inc.
  • B. Braun SE
  • Baxter Healthcare Corporation
  • Becton, Dickinson and Company
  • Cantel Medical Corp.
  • CapsulCN International Co., Ltd.
  • Codonics Inc.
  • Fagron N.V.
  • ForHealth Technologies
  • Fresenius Kabi AG
  • Grifols International S.A.
  • Health Robotics SRL
  • Loccioni Group
  • McKesson Corporation
  • Meditecno S.r.l.
  • Medtronic PLC
  • Omnicell, Inc.
  • Quirem Medical B.V.
  • ScriptPro LLC
  • Talyst LLC
  • Tecan Group Ltd.
  • Terumo Corporation
  • Yuyama Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated Compounding Devices Market, by Product Type
8.1. Introduction
8.2. Integrated Devices
8.3. Semi-Automated Devices
8.4. Stand-Alone Devices
9. Automated Compounding Devices Market, by Mode of Automation
9.1. Introduction
9.2. On-Demand Automation
9.3. Scheduled Automation
10. Automated Compounding Devices Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Homecare Settings
10.4. Hospitals
10.4.1. General Hospitals
10.4.2. Specialty Hospitals
10.5. Pharmacies
10.5.1. Hospital Pharmacies
10.5.2. Online Pharmacies
10.5.3. Retail Pharmacies
11. Automated Compounding Devices Market, by Application
11.1. Introduction
11.2. Chemotherapy
11.3. Diabetes Management
11.4. Nutrition Therapy
11.4.1. Enteral Nutrition
11.4.2. Parenteral Nutrition
11.5. Pain Management
12. Automated Compounding Devices Market, by Technology
12.1. Introduction
12.2. Automated Compounders
12.3. Robotic Technology
12.4. Software Solutions
12.4.1. Compounding Software
12.4.2. Inventory Management Software
13. Automated Compounding Devices Market, by User Interface
13.1. Introduction
13.2. Button Operated
13.3. Mobile Interface
13.4. Touch-Screen Interface
14. Automated Compounding Devices Market, by Dosage Form
14.1. Introduction
14.2. Inhalable Solutions
14.3. Injectables
14.4. Orals
14.5. Topical Solutions
15. Automated Compounding Devices Market, by Material Type
15.1. Introduction
15.2. Composite Materials
15.3. Metal
15.4. Plastic
16. Americas Automated Compounding Devices Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Automated Compounding Devices Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Automated Compounding Devices Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Amerisource Bergen Corporation
19.3.2. ARxIUM Inc.
19.3.3. B. Braun SE
19.3.4. Baxter Healthcare Corporation
19.3.5. Becton, Dickinson and Company
19.3.6. Cantel Medical Corp.
19.3.7. CapsulCN International Co., Ltd.
19.3.8. Codonics Inc.
19.3.9. Fagron N.V.
19.3.10. ForHealth Technologies
19.3.11. Fresenius Kabi AG
19.3.12. Grifols International S.A.
19.3.13. Health Robotics SRL
19.3.14. Loccioni Group
19.3.15. McKesson Corporation
19.3.16. Meditecno S.r.l.
19.3.17. Medtronic PLC
19.3.18. Omnicell, Inc.
19.3.19. Quirem Medical B.V.
19.3.20. ScriptPro LLC
19.3.21. Talyst LLC
19.3.22. Tecan Group Ltd.
19.3.23. Terumo Corporation
19.3.24. Yuyama Co., Ltd.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. AUTOMATED COMPOUNDING DEVICES MARKET MULTI-CURRENCY
FIGURE 2. AUTOMATED COMPOUNDING DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. AUTOMATED COMPOUNDING DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 20. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. AUTOMATED COMPOUNDING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. AUTOMATED COMPOUNDING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AUTOMATED COMPOUNDING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SEMI-AUTOMATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STAND-ALONE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ON-DEMAND AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SCHEDULED AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY AUTOMATED COMPOUNDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ROBOTIC TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INVENTORY MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BUTTON OPERATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MOBILE INTERFACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TOUCH-SCREEN INTERFACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INHALABLE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ORALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TOPICAL SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 95. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 97. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 99. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 100. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 101. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 113. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 152. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 154. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 157. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 159. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 161. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 162. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 163. CHINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 164. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 166. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 169. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 171. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 173. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 174. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 175. INDIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 178. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 188. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 190. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 193. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 195. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 197. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 198. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 199. JAPAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 200. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 202. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 248. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 250. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 260. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 262. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 265. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 267. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 269. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 270. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 271. THAILAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 297. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MODE OF AUTOMATION, 2018-2030 (USD MILLION)
TABLE 299. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 302. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NUTRITION THERAPY, 2018-2030 (USD MILLION)
TABLE 304. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 306. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY USER INTERFACE, 2018-2030 (USD MILLION)
TABLE 307. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 308. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 309. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (U

Companies Mentioned

  • Amerisource Bergen Corporation
  • ARxIUM Inc.
  • B. Braun SE
  • Baxter Healthcare Corporation
  • Becton, Dickinson and Company
  • Cantel Medical Corp.
  • CapsulCN International Co., Ltd.
  • Codonics Inc.
  • Fagron N.V.
  • ForHealth Technologies
  • Fresenius Kabi AG
  • Grifols International S.A.
  • Health Robotics SRL
  • Loccioni Group
  • McKesson Corporation
  • Meditecno S.r.l.
  • Medtronic PLC
  • Omnicell, Inc.
  • Quirem Medical B.V.
  • ScriptPro LLC
  • Talyst LLC
  • Tecan Group Ltd.
  • Terumo Corporation
  • Yuyama Co., Ltd.

Methodology

Loading
LOADING...